862P - Treatment and outcome after Immune checkpoint inhibitors (ICI) in metastatic Urothelial Carcinoma (mUC): A European perspective

Autor: Gomez de Liano Lista, A., Necchi, A., Lavaud, P., Carles Galceran, J., Castellano, D., Ravaud, A., Duran, I., van Dijk, N., Giannatempo, P., Loriot, Y., Morales Barrera, R., De Velasco Oria De Rueda, G., Lefort, F., Martínez Bernal, G., Raggi, D., Gross-Goupil, M., Powles, T., van der Heijden, M.
Zdroj: In Annals of Oncology September 2017 28 Supplement 5:v303-v303
Databáze: ScienceDirect